- Home
- SPXX vs SOPH Comparison
SPXX vs SOPH Comparison
Compare SPXX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPXX | SOPH |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.8M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPXX | SOPH |
|---|---|---|
| Price | $17.53 | $4.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 51.3K | ★ 105.6K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 7.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $13.57 | $2.58 |
| 52 Week High | $16.05 | $5.30 |
Technical Indicators
Market Signals| Indicator | SPXX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 55.20 |
| Support Level | $17.10 | $4.54 |
| Resistance Level | $18.09 | $4.84 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 44.55 | 42.11 |
Price Performance
Historical ComparisonAbout SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.